• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Assessing the Quality of Life of Metastatic Non-Small Cell Lung Cancer Patients after Chemotherapy: An Assessment Which Tells What's Next.

作者信息

Belloumi Nidhal, Habouria Chaima, Bachouch Imene, Ben Abdallah Fatma Chermiti, Fenniche Soraya

机构信息

Pulmonology Department Pavilion 4, Abderrahmen Mami Hospital, Ariana. Faculty of Medicine of Tunis, University of Tunis El manar, Tunisia.

出版信息

Tanaffos. 2023 Apr;22(4):349-352.

PMID:39176145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11338509/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5bd/11338509/47104e18ccb1/Tanaffos-22-349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5bd/11338509/47104e18ccb1/Tanaffos-22-349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5bd/11338509/47104e18ccb1/Tanaffos-22-349-g001.jpg

相似文献

1
Assessing the Quality of Life of Metastatic Non-Small Cell Lung Cancer Patients after Chemotherapy: An Assessment Which Tells What's Next.评估化疗后转移性非小细胞肺癌患者的生活质量：一项揭示后续情况的评估。
Tanaffos. 2023 Apr;22(4):349-352.
2
Combination immune checkpoint inhibitors with platinum-based chemotherapy in advanced non-small cell lung cancer: what's known and what's next.晚期非小细胞肺癌中免疫检查点抑制剂与铂类化疗联合应用：已知情况与未来展望
Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S447-S450. doi: 10.21037/tlcr.2019.11.10.
3
Chemotherapy for Stage IV Non-Small Cell Lung Cancer: Protocol Versus Nonprotocol? Is Noninvestigational Treatment Worthwhile? Patient Selection? Which Regimen? What's Next?IV期非小细胞肺癌的化疗：方案治疗与非方案治疗？非研究性治疗是否值得？患者选择？哪种方案？接下来是什么？
Semin Radiat Oncol. 1996 Apr;6(2):110-117. doi: 10.1053/SRAO00600110.
4
Immunotherapy supplanting chemotherapy for upfront treatment of advanced non-small cell lung cancer: what's next?免疫疗法取代化疗用于晚期非小细胞肺癌的一线治疗：接下来会怎样？
J Thorac Dis. 2017 May;9(5):E519-E521. doi: 10.21037/jtd.2017.03.155.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?PARP抑制剂与放射性代谢方法在转移性去势抵抗性前列腺癌中的应用：现状、新进展与未来趋势？
Cancers (Basel). 2022 Feb 11;14(4):907. doi: 10.3390/cancers14040907.
7
Quality of life after chemotherapy or hematopoietic cell transplant in follicular lymphoma: what's next?滤泡性淋巴瘤化疗或造血细胞移植后的生活质量：接下来会怎样？
Leuk Lymphoma. 2012 Mar;53(3):352-3. doi: 10.3109/10428194.2011.626884. Epub 2012 Jan 3.
8
Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What's next after taxane progression?去势抵抗性前列腺癌（AIPC）中的化疗：紫杉烷治疗进展后下一步该如何？
Cancer Ther. 2007;5A(A):151-160.
9
Future Hospital Commission - 10 years on. What's changed, what's new and what's next?未来医院委员会——十年之后。有哪些变化、有哪些新情况以及接下来会怎样？
Future Healthc J. 2024 Jul 12;11(2):100155. doi: 10.1016/j.fhj.2024.100155. eCollection 2024 Jun.
10
Binge eating disorder revisited: what's new, what's different, what's next - Addendum.暴饮暴食症再探讨：新变化、差异及未来走向——附录
CNS Spectr. 2019 Aug;24(S1):82. doi: 10.1017/S1092852919001366.

本文引用的文献

1
Comparison of Sleep Quality before and after Chemotherapy in Locally Advanced Nonsmall Cell Lung Cancer Patients: A Prospective Study.局部晚期非小细胞肺癌患者化疗前后睡眠质量的比较：一项前瞻性研究。
Sleep Disord. 2020 Jun 30;2020:8235238. doi: 10.1155/2020/8235238. eCollection 2020.
2
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial.系统与按需早期姑息治疗的比较：一项多中心随机临床试验的结果。
Eur J Cancer. 2016 Sep;65:61-8. doi: 10.1016/j.ejca.2016.06.007. Epub 2016 Jul 26.
3
RECIST 1.1-Update and clarification: From the RECIST committee.
RECIST 1.1更新与说明：来自RECIST委员会。
Eur J Cancer. 2016 Jul;62:132-7. doi: 10.1016/j.ejca.2016.03.081. Epub 2016 May 14.
4
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975.患者自我报告的健康相关生活质量是否是非小细胞肺癌患者生存的预后因素？欧洲癌症研究与治疗组织（EORTC）08975研究预后因素的多变量分析。
Ann Oncol. 2006 Nov;17(11):1698-704. doi: 10.1093/annonc/mdl183. Epub 2006 Sep 12.